The incidence of Candida glabrata infections increases every year due to its higher resistance to commonly used antifungal drugs. We characterized the antifungal mechanism of action of eight new styrylpyridinium derivatives, with various N-alkyl chains (-C6H13, -C8H17, -C10H21, -C12H25) and different substituents, on C. glabrata strains differing in their drug resistance due to the presence or absence of two major drug-efflux pumps. We found that the tested styrylpyridinium compounds affected the growth of C. glabrata cells in a compound- and strain-dependent manner, and apparently they were substrates of CgCdr1 and CgCdr2 pumps. Further, we determined the impact of the tested compounds on plasma membrane integrity. The ability to cause damage to a plasma membrane depended on the compound, its concentration and the presence of efflux pumps, and corresponded well with the results of growth and survival tests. We also tested possible synergism with three types of known antifungal drugs. Though we did not observe any synergism with azole drugs, styrylpyridinium compounds 5 and 6 together with FK506 demonstrated excellent antifungal properties, whereas compounds 2, 3, 5, and 6 exhibited a significant synergistic effect in combination with terbinafine. Based on our results, derivatives 2 and 6 turned out to be the most promising antifungal drugs. Moreover, compound 6 was not only able to effectively permeabilize the yeast plasma membrane, but also exhibited significant synergism with FK506 and terbinafine. Finally, we also characterized the spectroscopic properties of the tested styrylpyridinium compounds. We measured their absorption and fluorescence spectra, determined their localization in yeast cells and found that their fluorescence characteristics differ from the properties of current commercial vacuolar styrylpyridinium markers and allow multi-color staining. Compounds 1, 3, 7, and 8 were able to accumulate in plasma and vacuolar membranes, and compounds 2, 5, and 6 stained the whole interior of dead cells. In summary, of the eight tested compounds, compound 6 is the most promising antifungal drug, compound 8, due to its minimal toxicity, is the best candidate for a new vacuolar-membrane probe or new benchmark substrate of C. glabrata Cdr pumps, and derivative 5 for a new vital dye.

Department of Biochemistry Faculty of Natural Sciences Vytautas Magnus University Kaunas Lithuania

Laboratory of Membrane Transport Division Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University Institute of Physiology of the Czech Academy of Sciences Vestec Czechia

Zobrazit více v PubMed

Barchiesi F., Di Francesco L. F., Compagnucci P., Arzeni D., Giacometti A., Scalise G. (1998). PubMed DOI

Bolte S., Talbot C., Boutte Y., Catrice O., Read N. D., Satiat-Jeunemaitre B. (2004). FM-dyes as experimental probes for dissecting vesicle trafficking in living plant cells. PubMed

Campoy S., Adrio J. L. (2017). Antifungals. PubMed

Cannon R. D., Lamping E., Holmes A. R., Niimi K., Baret P. V., Keniya M. V., et al. (2009). Efflux-mediated antifungal drug resistance. PubMed PMC

Chanawanno K., Chantrapromma S., Anantapong T., Kanjana-Opas A., Fun H. K. (2010). Synthesis, structure and PubMed DOI

Cruz M. C., Goldstein A. L., Blankenship J. R., Del Poeta M., Davis D., Cardenas M. E., et al. (2002). Calcineurin is essential for survival during membrane stress in PubMed DOI PMC

Denardi L. B., Mario D. A. N., Loreto E. S., Santurio J. M., Alves S. H. (2015). Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant PubMed DOI PMC

Denksteinová B., Gášková D., Heřman P., Večeř J., Malínský J., Plášek J., et al. (1997). Monitoring of membrane potential changes in PubMed DOI

Dubur G. Y., Dobretsov G. E., Deme A. K., Dubure R. R., Lapshin E. N., Spirin M. M. (1984). Fluorescent probes based on styrylpyridinium derivatives: optical properties and membrane binding. PubMed DOI

Gao Z., Hao Y., Zheng M., Chen Y. (2017). A fluorescent dye with large Stokes shift and high stability: synthesis and application to live cell imaging. DOI

Gášková D., Brodská B., Heřman P., Večeř J., Malínský J., Sigler K., et al. (1998). Fluorescent probing of membrane potential in walled cells: diS-C PubMed DOI

Heese-Peck A., Pichler H., Zanolari B., Watanabe R., Daum G., Riezman H. (2002). Multiple functions of sterols in yeast endocytosis. PubMed DOI PMC

Jung J. A., Yoon Y. J. (2020). Development of non-immunosuppressive FK506 derivatives as antifungal and neurotrophic agents. PubMed DOI PMC

Kodedová M., Sigler K., Lemire B. D., Gášková D. (2011). Fluorescence method for determining the mechanism and speed of action of surface-active drugs on yeast cells. PubMed DOI

Kodedová M., Sychrová H. (2016). High-throughput fluorescence screening assay for the identification and comparison of antimicrobial peptides’ activity on various yeast species. PubMed DOI

Kodedová M., Valachovič M., Csáky Z., Sychrová H. (2019). Variations in yeast plasma-membrane lipid composition affect killing activity of three families of insect antifungal peptides. PubMed DOI

Krieg R., Eitner A., Günther W., Halbhuber K. J. (2007). Optimization of heterocyclic 4-hydroxystyryl derivatives for histological localization of endogenous and immunobound peroxidase activity. PubMed DOI

Ksiezopolska E., Gabaldón T. (2018). Evolutionary emergence of drug resistance in PubMed DOI PMC

Mathé L., Van Dijck P. (2013). Recent insights into PubMed DOI PMC

Miner G. E., Sullivan K. D., Zhang C., Hurst L. R., Starr M. L., Rivera-Kohr D. A., et al. (2019). Copper blocks V-ATPase activity and SNARE complex formation to inhibit yeast vacuole fusion. PubMed PMC

Mishra B. K., Behera P. K., Rath R. (2001). Acid dissociation constants of N-alkyl p/o-hydroxy styryl pyridinium dyes in surfactant solutions.

Pais P., Galocha M., Viana R., Cavalheiro M., Pereira D., Teixeira M. C. (2019). Microevolution of the pathogenic yeasts PubMed DOI PMC

Park H. S., Lee S. C., Cardenas M. E., Heitman J. (2019). Calcium-calmodulin-calcineurin signaling: a globally conserved PubMed DOI PMC

Petrikkos G., Skiada A. (2007). Recent advances in antifungal chemotherapy. PubMed DOI

Puri N., Manoharlal R., Sharma M., Sanglard D., Prasad R. (2011). Overcoming the heterologous bias: an PubMed DOI

Sanglard D., Ischer F., Bille J. (2001). Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in PubMed DOI PMC

Sanglard D., Ischer F., Calabrese D., Majcherczyk P. A., Bille J. (1999). The ATP binding cassette transporter gene PubMed DOI PMC

Scheid L. A., Mario D. A. N., Kubiça T. F., Santurio J. M., Alves S. H. (2012). PubMed DOI

Shiraishi Y., Inoue T., Hirai T. (2010). Local viscosity analysis of triblock copolymer micelle with cyanine dyes as a fluorescent probe. PubMed DOI

Shrestha S. K., Fosso M. Y., Garneau-Tsodikova S. (2015). A combination approach to treating fungal infections. PubMed DOI PMC

Urai M., Kaneko Y., Niki M., Inoue M., Tanabe K., Umeyama T., et al. (2014). Potent drugs that attenuate anti- PubMed DOI

Vaitkienė S., Kuliešinė N., Sakalauskaitė S., Bekere L., Krasnova L., Vigante B., et al. (2020). Antifungal activity of styrylpyridinium compounds against PubMed DOI

Wyrzykiewicz E., Prukała W., Kędzia B. (1994). Synthesis and antimicrobial properties of N-substituted derivatives of (E)-α-(or γ)-azastilbenols. PubMed